Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action.Daniel JP, Mesquita FP, Da Silva EL, de Souza PFN, Lima LB, de Oliveira LLB, de Moraes MEA, Moreira-Nunes CFA, Burbano RMR, Zanatta G, Montenegro RC.Front Pharmacol. 2022 Aug 25;13:952250. doi: 10.3389/fphar.2022.952250. eCollection 2022.PMID: 36091760 Free PMC article.
